Skip to main content
Eurofins Scientific SE logo

Eurofins Scientific SE — Investor Relations & Filings

Ticker · ESF0 ISIN · FR0014000MR3 LEI · 529900JEHFM47DYY3S57 PA Professional, scientific and technical activities
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2026-03-23 Proxy Solicitation & In…
Country LU Luxembourg
Listing PA ESF0

About Eurofins Scientific SE

https://www.eurofins.com/

Eurofins Scientific is a global group of laboratories providing a comprehensive range of analytical testing services. The company is a world leader in food, environmental, pharmaceutical, and cosmetic product testing. Its portfolio also extends to agroscience contract research organization (CRO) services and specialized offerings in discovery pharmacology, early-stage pharmaceutical development, central laboratory support, and biopharma product testing. Operating through an extensive international network of laboratories, Eurofins delivers bio-analytical services to ensure the safety, identity, purity, composition, and authenticity of a wide variety of products and substances for clients across numerous industries.

Recent filings

Filing Released Lang Actions
Modalités de mise à disposition des documents préparatoires à l'AG
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of convocation to the Annual General Meeting and Extraordinary General Meeting of Eurofins Scientific SE, including the full agenda, procedures for submitting resolutions, proxy voting instructions, record dates, and participation requirements. It is sent to shareholders to inform them of meeting details and solicit their votes. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-23 French
Eurofins Scientific SE - Convening Notice (EN) - AGM 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the official convening notice (avis de convocation) for the Annual Ordinary and Extraordinary General Meetings, containing the meeting agendas, date, time, location, procedures for participation, voting by proxy or mail, record date, and related shareholder/bondholder information. It is not the actual meeting minutes, financial statements, or an earnings announcement, nor a simple publication announcement. This type of material—providing detailed information to solicit proxies and inform shareholders ahead of a vote—matches the Proxy Solicitation & Information Statement category (PSI).
2026-03-23 English
Eurofins Scientific SE - Avis de convocation (FR) - AGM 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a notice of convocation for an annual and extraordinary general shareholders meeting, including the agenda items, proxy voting instructions, record date details, and procedures for submitting resolutions and questions. It is sent to shareholders to provide information and solicit votes ahead of the meeting, fitting the Proxy Solicitation & Information Statement category rather than the meeting materials themselves (AGM presentations) or the meeting results.
2026-03-23 French
2026.03.20
Director's Dealing Classification · 1% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically François Vigneau, Senior Vice President of Eurofins Scientific. It follows the standard format for 'Notification and Public Disclosure of Transactions' required under the European Market Abuse Regulation. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2026-03-20 English
2026.03.18
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by a Person Discharging Managerial Responsibilities (PDMR), specifically Analytical Bioventures S.C.A., which is controlled by the CEO of Eurofins Scientific. It explicitly follows the European Market Abuse Regulation disclosure requirements for insider dealings. This fits the definition of 'Director's Dealing' (DIRS).
2026-03-18 English
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document is a weekly report detailing the company's share repurchase activities, including transaction dates, volumes, and weighted average prices. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share buyback disclosures.
2026-03-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.